As it is known that CD94+ NK cells can be activated by Hsp70 in an inflammatory microenvironment [30], we further speculated that increased proportions of CD94+ NK cells in the peripheral blood of patients with lung cancer before surgery is associated with a better, recurrence-free outcome. This evidence concerns the gene KLRD1 and lung carcinoma.